Intravitreal Bevacizumab and Intravitreal Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA).
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2013
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms IBeTA
- 01 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2009 New trial record